Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study

Recruiting now

Conditions studied: Uncontrolled Asthma

In brief

This study is a multi-centre, non-interventional, observational, ambispective registry. Planned study population consists of 9 000 adult patients with uncontrolled asthma receiving treatment according to standard of care (except biologics). Planned number of study site is 70 outpatient centers with experience of uncontrolled asthma treatment in about 50 regions of Russia (in order to describe characteristics of patients with uncontrolled asthma in different regions in the most comprehensive way).

Key facts

Study ID: NCT06521229
Run by: AstraZeneca
People needed: 9000
Starts: 2024-06-27
Expected to finish: 2026-09-30
Last updated by the study team: 2026-04-20

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Age ≥ 18 years at the time of inclusion;
Signed and dated written informed consent in accordance with ICH GCP and local law prior to inclusion in the study;
Patients with diagnosis of uncontrolled mild and moderate asthma (according to Global Initiative for Asthma (GINA) score);
Patients with the availability of at least 52 weeks of follow-up data (prior to inclusion) in the medical records.

You may not qualify if…

Patients with severe asthma or/and patients receiving any biological therapy currently or within 52 weeks prior to inclusion;
Presence of chronic obstructive pulmonary disease (COPD) or idiopathic pulmonary fibrosis (ILF) currently or in the anamnesis;
The participation in any clinical study currently or within 52 weeks prior to inclusion;
An acute or chronic disease that, as deemed by Investigator, limits the ability of patients to participate in this study or could influence the interpretation of the results.

Where it is running

Research Site — Yuzhno-Sakhalinsk, Russia (enrolling)
Research Site — Vladivostok, Russia (enrolling)
Research Site — Voronezh, Russia (enrolling)
Research Site — Yaroslavl, Russia (enrolling)
Research Site — Yekaterinburg, Russia (enrolling)
Research Site — Astrakhan, Russia (enrolling)
Research Site — Bryansk, Russia (enrolling)
Research Site — Chelyabinsk, Russia (enrolling)
Research Site — Gatchina, Russia (enrolling)
Research Site — Irkutsk, Russia (enrolling)
Research Site — Ivanovo, Russia (enrolling)
Research Site — Izhevsk, Russia (enrolling)
Research Site — Kazan', Russia (enrolling)
Research Site — Kemerovo, Russia (enrolling)
Research Site — Krasnodar, Russia (enrolling)
Research Site — Krasnoyarsk, Russia (enrolling)
Research Site — Lipetsk, Russia (enrolling)
Research Site — Makhachkala, Russia (enrolling)
Research Site — Moscow, Russia (enrolling)
Research Site — Murmansk, Russia (enrolling)
Research Site — Nal'chik, Russia (enrolling)
Research Site — Nizhny Tagil, Russia (enrolling)
Research Site — Novokuznetsk, Russia (enrolling)
Research Site — Novosibirsk, Russia (enrolling)
Research Site — Omsk, Russia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.